Evidence map›Paper›PMID 25408354›Full record

ArticleAdvances in experimental medicine and biology2015

N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic.

Aditi Banerjee, Juan A Martinez, Maria O Longas, Zhenbo Zhang, Jesus Santiago, Krishna Baksi, Dipak K Banerjee

Abstract read
In one paragraph

Article in Advances in experimental medicine and biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. BIRTH OF A GLYCOTHERAPY FOR BREAST CANCER.Trends in carbohydrate research · 2023
    Article
  2. Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor.Angewandte Chemie (International ed. in English) · 2022
    Article
  3. Review
  4. Structure-based drug discovery by targetingFuture medicinal chemistry · 2019
    Article
  5. Inhibition ofJournal of molecular pharmaceutics & organic process research · 2018
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aditi BanerjeeDepartment of Pediatrics, School of Medicine, University of Maryland, Baltimore, MD, 21202, USA.
Juan A Martinez
Maria O Longas
Zhenbo Zhang
Jesus Santiago
Krishna Baksi
Dipak K Banerjee

Funding

UNIVERSITY MEDICAL RESEARCH CENTERG12RR003035 · NCRR · UNIVERSIDAD CENTRAL DEL CARIBE · PI ROJAS, LEGIER V · 1986 to 2011
$26.7M
UNIVERSIDAD CENTRAL DEL CARIBE BIOMEDICAL RESEARCH CENTERSG12MD007583 · NIMHD · UNIVERSIDAD CENTRAL DEL CARIBE · PI RODRIGUEZ, JOSE GINEL · 2012 to 2016
$8.4M
NCRR NIH HHS G12 RR003035NIMHD NIH HHS 2G12MD007583NIMHD NIH HHS G12 MD007583
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Xenograft Model Antitumor AssaysAnimalsBreast NeoplasmsCell LineCell Line, TumorCell ProliferationDNA FragmentationDose-Response Relationship, DrugEndoplasmic Reticulum StressFemaleHumansMice, NudeNeovascularization, PathologicPhosphorylationSpectrum Analysis, RamanTime FactorsTransferases (Other Substituted Phosphate Groups)TunicamycinUDPacetylglucosamine-dolichyl-phosphate acetylglucosamine-1-phosphate transferaseVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2

Identifiers

PMID25408354
PMCPMC4603827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.